Asia-pacific Cardiovascular Ultrasound Market 2022-2028

Asia-pacific Cardiovascular Ultrasound Market 2022-2028

MARKET OUTLOOK

A report by Triton Market Research depicts that the cardiovascular ultrasound market in the Asia-Pacific will advance with a CAGR of 6.83% over the projected duration between 2022 and 2028. India, Japan, China, Australia & New Zealand, ASEAN countries, South Korea, and Rest of Asia-Pacific are evaluated in the market in this region.

Since the past two decades, the number of patients suffering from heart failure in Japan has grown rapidly, and has become a crucial issue in the fields of medical practice and public health. As a result, the demand for electrocardiography devices to detect cardiovascular diseases on time has increased. Also, manufacturers are focusing on incorporating advanced technologies into ultrasound machines. These factors are fueling the studied market’s growth in Japan.

In India, non-communicable diseases, such as cardiovascular disease (CVD), cancer, and others, account for nearly 60% of all deaths. In fact, CVDs are now the leading cause of death among Indians. Some factors associated with the cardiovascular disease epidemic in the nation are particularly alarming, such as its rapid spread, disease onset at a young age, and the high mortality rate. Cardiovascular ultrasound machines are thus witnessing high demand. Key players like Siemens Healthineers, Philips Healthcare, and others, are offering their products to meet the rising needs of the healthcare sector and to aid in timely disease detection & treatment. This, in turn, is expected to drive the market growth in the long run.

COMPETITIVE OUTLOOK

Some of the acclaimed players in the cardiovascular ultrasound market are Canon Medical Corp, Telemed Ultrasound Medical Systems, Samsung Medison Co Ltd, Lanmage, Esaote S.p.A., Dawei Medical, Siemens Healthineers, and Mindray Medical International Limited.